Latest Convertible Notes News

Page 27 of 68
Northern Minerals reports a robust Definitive Feasibility Study and secures conditional funding interest, positioning Browns Range as a critical supplier of heavy rare earths by 2028.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Spenda Limited reported a record $204 million in payment volumes for Q1 FY26 alongside a strategic cost reduction of 21% annualised. The quarter also saw a significant leadership change with the resignation of its Managing Director.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Linius Technologies has implemented a sweeping operational restructure, cutting expenses by more than 60% compared to FY25, while progressing a pivotal proof of concept with a major European football league and securing over $3.7 million in new funding.
Sophie Babbage
Sophie Babbage
31 Oct 2025
RBR Group Limited is positioning itself for expansion with over US$35 million in tenders amid the restart of Mozambique's LNG mega projects following the lifting of Force Majeure by Total Energies.
Maxwell Dee
Maxwell Dee
31 Oct 2025
FirstWave Cloud Technology reports a cash-flow positive quarter with a $2.85 million capital raise and advances its AI-powered compliance product, targeting a commercial release by November.
Sophie Babbage
Sophie Babbage
31 Oct 2025
GBM Resources has launched a major drilling campaign at its Twin Hills gold project and raised A$40 million to fund exploration and development across its Drummond Basin portfolio.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Australian Bond Exchange Holdings (ASX – ABE) unveiled new AUD-denominated market-linked securities and progressed its AI-driven credit analysis tool, while reporting a $0.7 million quarterly cash outflow and plans for capital raising.
Claire Turing
Claire Turing
31 Oct 2025
Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.
Ada Torres
Ada Torres
31 Oct 2025
Invion Limited has secured a pivotal FDA Orphan Drug Designation for its lead cancer drug INV043, bolstered its balance sheet with nearly $1.8 million in new funding, and progressed clinical trials targeting skin and anogenital cancers.
Ada Torres
Ada Torres
31 Oct 2025
BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.
Ada Torres
Ada Torres
31 Oct 2025
Visionflex Group reported a $999,000 cash outflow for Q1 2025 but bolstered its liquidity with $1.9 million in financing, including plans to convert $3 million of convertible notes into equity pending shareholder approval.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Audio Pixels Holdings has made significant technical strides in its MEMS-based Digital Sound Reconstruction technology while securing $1.25 million in new convertible note funding. Despite progress, the company remains suspended from ASX pending further capital raises.
Sophie Babbage
Sophie Babbage
31 Oct 2025